Chronic Fenfluramine Administration Increases Plasma Serotonin (5-Hydroxytryptamine) to Nontoxic Levels

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2008-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.107.132654PMID 18032571
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Drugs and valvular heart disease.

  2007cited by this paper
• The potential use of selective 5-HT2C agonists in treating obesity

  2006influential reference
• Amphetamine Analogs Increase Plasma Serotonin: Implications for Cardiac and Pulmonary Disease

  2006influential reference
• 5‐HYDROXYTRYPTAMINE IN THE CARDIOVASCULAR SYSTEM: FOCUS ON THE SEROTONIN TRANSPORTER (SERT)

  2006cited by this paper
• Cross talk between endothelial and smooth muscle cells in pulmonary hypertension: critical role for serotonin-induced smooth muscle hyperplasia.

  2006cited by this paper
• Long-Term Serotonin Administration Induces Heart Valve Disease in Rats

  2005influential reference
• Increased plasma free serotonin but unchanged platelet serotonin in bipolar patients treated chronically with lithium

  2004cited by this paper
• Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?

  2002cited by this paper
• Therapeutic and adverse actions of serotonin transporter substrates.

  2002cited by this paper
• Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension

  2002influential reference
• Profiling of tryptophan-related plasma indoles in patients with carcinoid tumors by automated, on-line, solid-phase extraction and HPLC with fluorescence detection.

  2001influential reference
• Serum Concentrations of Fluoxetine in the Clinical Treatment Setting

  2001cited by this paper
• 1-(m-Chlorophenyl)piperazine (mCPP) Dissociates In Vivo Serotonin Release from Long-Term Serotonin Depletion in Rat Brain

  2001influential reference
• Chronic treatment with phentermine combined with fenfluramine lowers plasma serotonin.

  2000influential reference
• Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

  2000influential reference
• Discriminating capacity of indole markers in the diagnosis of carcinoid tumors.

  2000influential reference
• Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications

  2000cited by this paper
• 5‐hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension

  2000influential reference
• Aminorex to fen/phen: an epidemic foretold.

  1999influential reference
• Obesity drugs and the heart.

  1999cited by this paper
• Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: Effects of clomipramine and fluoxetine

  1999cited by this paper
• Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia.

  1998cited by this paper
• Appetite-suppressant Drugs and the Risk of Primary Pulmonary Hypertension?

  1997cited by this paper
• Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

  1995influential reference
• Improved diagnosis of carcinoid tumors by measurement of platelet serotonin.

  1992influential reference
• Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement.

  1992cited by this paper
• Simultaneous Effects of p‐Chloroamphetamine, d‐Fenfluramine, and Reserpine on Free and Stored 5‐Hydroxytryptamine in Brain and Blood

  1992cited by this paper

• The Continued Mismeasurement of Plasma Serotonin: A Systematic Review.

  2025cites this paper
• Antiobesity medications in adult and pediatric obesity and metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Imipramine Increases Norepinephrine and Serotonin in the Salivary Glands of Rats

  2024cites this paper
• The Discovery of 5-HT2B Receptor Pharmacology Through the Understanding of Drug-Induced Valvulopathy

  2021cites this paper
• Quantitation of Four Tryptophan-Related Impurities in Compound Amino Acid Injection-18 AA by HPLC–PDA

  2019cites this paper
• 5-HTT mRNA level as a potential biomarker of treatment response in patients with major depression in a clinical trial.

  2018cites this paper
• Anorexigen-Associated Pulmonary Arterial Hypertension and the Serotonin Hypothesis: A Story Worth Telling

  2018cites this paper
• Serotonin and brain function: a tale of two receptors

  2017cites this paper
• Serum serotonin levels and bone in rheumatoid arthritis patients

  2017cites this paper
• Brainwide mapping of endogenous serotonergic transmission via chemogenetic-fMRI

  2017cites this paper
• The Associations of Serum Serotonin with Bone Traits Are Age- and Gender-Specific

  2014cites this paper
• MDMA pharmacology in humans and serotonergic effects

  2013cites this paper
• Platelet SERT as a peripheral biomarker of serotonergic neurotransmission in the central nervous system.

  2013cites this paper
• Platelets in Pulmonary Hypertension: a Causative Role or a Simple Association?

  2012cites this paper
• Altered Gene Expression in Pulmonary Tissue of Tryptophan Hydroxylase-1 Knockout Mice: Implications for Pulmonary Arterial Hypertension

  2011cites this paper
• Valvular heart disease associated with benfluorex therapy: results from the French multicentre registry.

  2011cites this paper
• The emerging role of serotonin (5-hydroxytryptamine) in the skeleton and its mediation of the skeletal effects of low-density lipoprotein receptor-related protein 5 (LRP5).

  2010cites this paper
• Psychotropic drugs have contrasting skeletal effects that are independent of their effects on physical activity levels.

  2010cites this paper
• Update in serotonin and bone.

  2010cites this paper
• Organ culture as a tool to identify early mechanisms of serotonergic valve disease.

  2010cites this paper
• Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.

  2010cites this paper
• Restrictive organic mitral regurgitation associated with benfluorex therapy.

  2010cites this paper
• Valvular heart disease associated with benfluorex therapy : results from the French multicentre registry

  2010cites this paper
• The serotonin hypothesis of pulmonary hypertension revisited.

  2010cites this paper
• Fenfluramine disrupts the mitral valve interstitial cell response to serotonin.

  2009cites this paper
• Serotonin and pulmonary hypertension--from bench to bedside?

  2009cites this paper
• KYNURENINE METABOLITES AND INFLAMMATION MARKERS IN DEPRESSED PATIENTS TREATED WITH FLUOXETINE OR COUNSELLING

  2009cites this paper
• Remodeling of the extracellular matrix components of the mitral valve due to alterations in the mechanical and chemical environments of the tissue

  2009cites this paper
• Drug-induced fibrotic valvular heart disease.

  2009cites this paper
• Role of echocardiography in toxic heart valvulopathy.

  2009cites this paper
• Serotonergic drugs and valvular heart disease

  2009cites this paper
• Dopamine/serotonin releasers as medications for stimulant addictions.

  2008cites this paper
• Serotonin (5‐HT) Transporter Ligands Affect Plasma 5‐HT in Rats

  2008cites this paper
• Dual dopamine/serotonin releasers: potential treatment agents for stimulant addiction.

  2008cites this paper